Ardelyx, Inc. (ARDX), a biopharmaceutical company, Wednesday, announced that it has appointed Rajani Dinavahi as its Chief Medical Officer.
Dinavahi brings more than two decades of experience in healthcare and biotechnology and has most recently served as the Senior Vice President, Chief Medical Officer at Atara Biotherapeutics.
In pre-market activity, ARDX shares were trading at $6.06, up 1.25% on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.